Astellas Pharma: Raising New, As Yet Unanswered Questions In Stomach Cancer And Moving Their Pipeline ForwardBy mariocazombo76@gmail.com / March 15, 2025
Immutep Limited: Continuing To Make The Case For Eftilagimod January 28, 2025 / Galzus Research, IMMP, PRRUF / By mariocazombo76@gmail.com
Bicara Therapeutics: A Decline Off The IPO Spells ‘Wait’ For Me February 2, 2025 / BCAX, Galzus Research / By mariocazombo76@gmail.com